EXONICS THERAPEUTICS, INC.

Profile

Company Names

EXONICS THERAPEUTICS, INC.

Addresses

490 ARSENAL WAY, SUITE 110, WATERTOWN, MA 02472

1 BROADWAY, 14TH FLOOR, CAMBRIDGE, MA 02142

Phone Numbers

781-749-3987

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$22,043,962.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2017-11-07 
$22,043,962.00 
$42,043,965.00 
$20,000,003.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
 
GOEDDEL 
DIRECTOR
IGENICA INC   |  NGM BIOPHARMACEUTICALS INC   |  CONSTELLATION PHARMACEUTICALS INC   |  PELOTON THERAPEUTICS, INC.   |  NURIX, INC.   |  NEURONA THERAPEUTICS INC   |  IGENICA BIOTHERAPEUTICS, INC   |  FLX BIO, INC.   |  EXONICS THERAPEUTICS, INC.   |  SURROZEN, INC.   |  A2 BIOTHERAPEUTICS, INC.   |  HEXAGON BIO INC.   |  COLUMN GROUP V, LP   |  COLUMN GROUP OPPORTUNITY III, LP   |  COLUMN GROUP SPV I, LP   |  NGM BIO HOLDINGS, INC.
JESPER 
 
GROMADA 
EXECUTIVE OFFICER
EXONICS THERAPEUTICS, INC.
JEENJOO 
 
KANG 
DIRECTOR
EXONICS THERAPEUTICS, INC.   |  ESCIENT PHARMACEUTICALS INC
H. 
JAMES 
MAGEE 
EXECUTIVE OFFICER
EXONICS THERAPEUTICS, INC.
ROGER 
 
PERLMUTTER 
DIRECTOR
IMMUNE DESIGN CORP.   |  EXONICS THERAPEUTICS, INC.
JOHN 
 
RIPPLE 
EXECUTIVE OFFICER, DIRECTOR
VIRDANTE PHARMACEUTICALS, INC.   |  EXONICS THERAPEUTICS, INC.   |  LUCY THERAPEUTICS, INC.   |  PRAESIDIA BIOTHERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-11-20
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-07 
2017-11-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#